32 results
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
own benefits and risks ... the hypoglycemia risk ... pharmacotherapy #table
Effective radiation dose in adults - Following are comparisons of effective radiation dose in adults with
Nuclear #Comparison #Table ... #Risks
Chest Pain Diagnosis and Management Algorithm
STEMI:
 - Hx: Pressure like CP, Radiation to arm/jaw, CAD risk
and Management Algorithm ... to arm/jaw, CAD risk ... severe, tearing CP, Risks ... CP, Dyspnea, PE risk ... Diagnosis #Management #Algorithm
IDSA Algorithm for the Initial Management of Fever and Neutropenia

LOW RISK
 • Antidpated neutropenia < 7
IDSA Algorithm for ... Neutropenia LOW RISK ... and clinically stable ... comorbidities HIGH RISK ... #fever #IDSA #Algorithm
Risk factors for osteoporosis

#Diagnosis #Osteoporosis #Risks #Factors #Table
Risk factors for ... #Osteoporosis #Risks ... #Factors #Table
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
, may consider risks ... #Pharmacology #Table
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
functional status - Able ... metabolic equivalent able ... event, follow ACC algorithm ... Stable patients ... CARP, DECREASE V trials
AACE/ACE 2016 Postmenopausal Osteoporosis Treatment Algorithm

Evaluate for causes of secondary osteoporosis

Correct calcium/vitamin D deficiency and address
Osteoporosis Treatment Algorithm ... , benefits and risks ... Postmenopausal #Treatment #Algorithm
Sensitivity is the proportion of truly diseased persons in the screened population who are identified as
implies being able ... test is one that picks ... it has a narrow focus ... #Calculation #Table
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
Selected Clinical Trials ... ASCVD or ASCVD risk ... ASCVD or ASCVD risk ... visualabstract #table